🇪🇺 Canakinumab Injection in European Union

Canakinumab Injection (canakinumab-injection) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Canakinumab Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Canakinumab Injection approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Canakinumab Injection in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.